3,688
edits
Upper Endoscopy: Difference between revisions
no edit summary
No edit summary Tags: Mobile edit Mobile web edit |
No edit summary |
||
| Line 2: | Line 2: | ||
[https://pubmed.ncbi.nlm.nih.gov/9768765/ Gastric contents in children presenting for upper endoscopy] | [https://pubmed.ncbi.nlm.nih.gov/9768765/ Gastric contents in children presenting for upper endoscopy] | ||
Chehade M, Dellon ES, Spergel JM, et al. Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age. The New England journal of medicine 2024;390(24):2239-2251. (In eng). DOI: 10.1056/NEJMoa2312282. | |||
2. Rothenberg ME, Dellon ES, Collins MH, et al. Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol 2023;8(11):990-1004. (In eng). DOI: 10.1016/s2468-1253(23)00204-2. | |||